<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Moret F</submitter><funding>Associazione Italiana per la Ricerca sul Cancro</funding><funding>Regione Campania</funding><pagination>2488-2500</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9458690</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12(10)</volume><pubmed_abstract>A biodegradable engineered nanoplatform combining anti-angiogenic activity and targeting of cancer cells to improve the anticancer activity of docetaxel (DTX) is here proposed. Indeed, we have developed biodegradable nanoparticles (NPs) of poly(ethylene glycol)-poly(ε-caprolactone), exposing on the surface both folate motifs (Fol) for recognition in cells overexpressing Folate receptor-α (FRα) and the anti-angiogenic hexapeptide aFLT1. NPs showed a size around 100 nm, the exposure of 60% of Fol moieties on the surface, and the ability to entrap DTX and sustain its release with time. NPs were stable in simulated biological fluids and slightly interacted with Fetal Bovine serum, especially in the formulation decorated with Fol and aFLT1. The presence of Fol on NPs did not impair the anti-ang</pubmed_abstract><journal>Drug delivery and translational research</journal><pubmed_title>Biodegradable nanoparticles combining cancer cell targeting and anti-angiogenic activity for synergistic chemotherapy in epithelial cancer.</pubmed_title><pmcid>PMC9458690</pmcid><funding_grant_id>B61G18000470007</funding_grant_id><funding_grant_id>15764</funding_grant_id><pubmed_authors>Laurienzo P</pubmed_authors><pubmed_authors>Dal Poggetto G</pubmed_authors><pubmed_authors>Avitabile C</pubmed_authors><pubmed_authors>Reddi E</pubmed_authors><pubmed_authors>Quaglia F</pubmed_authors><pubmed_authors>Ungaro F</pubmed_authors><pubmed_authors>Romanelli A</pubmed_authors><pubmed_authors>Conte C</pubmed_authors><pubmed_authors>Moret F</pubmed_authors><pubmed_authors>Tiso N</pubmed_authors><pubmed_authors>Esposito D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Biodegradable nanoparticles combining cancer cell targeting and anti-angiogenic activity for synergistic chemotherapy in epithelial cancer.</name><description>A biodegradable engineered nanoplatform combining anti-angiogenic activity and targeting of cancer cells to improve the anticancer activity of docetaxel (DTX) is here proposed. Indeed, we have developed biodegradable nanoparticles (NPs) of poly(ethylene glycol)-poly(ε-caprolactone), exposing on the surface both folate motifs (Fol) for recognition in cells overexpressing Folate receptor-α (FRα) and the anti-angiogenic hexapeptide aFLT1. NPs showed a size around 100 nm, the exposure of 60% of Fol moieties on the surface, and the ability to entrap DTX and sustain its release with time. NPs were stable in simulated biological fluids and slightly interacted with Fetal Bovine serum, especially in the formulation decorated with Fol and aFLT1. The presence of Fol on NPs did not impair the anti-ang</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Oct</publication><modification>2025-04-19T20:35:04.221Z</modification><creation>2025-04-19T20:35:04.221Z</creation></dates><accession>S-EPMC9458690</accession><cross_references><pubmed>34973132</pubmed><doi>10.1007/s13346-021-01090-6</doi></cross_references></HashMap>